Global Nasal Spray Market - Industry Trends and Forecast to 2024

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email

Global Nasal Spray Market – Industry Trends and Forecast To 2024

Reports

Global Nasal Spray Market, By Type (Decongestant nasal spray, salt water solution/ saline nasal spray, steroid nasal spray), By Container Design (Pressurized Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-dose, multi-dose), By Prescription (Prescribed, Over-the-counter), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By Application (Allergic and non-allergic Rhinitis, Nasal Congestion, CNS disorders, Vaccination, Others), End User (Hospital, ASC/Clinics, Home Care Setting, Pharmacy, Others), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024

$4,200.00
Clear selection
Want create site? Find Free WordPress Themes and plugins.

Global nasal spray market is expected to reach USD 19.4 billion by 2024 from USD 11.9  billion in 2016, at a CAGR of 6.3% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Factors which may drive the growth of the nasal spray include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, painless,rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. It is found that allergic rhinitis affects 10 to 30% of children and adults in the U.S. and other industrialized countries. Prevalence of allergic rhinitis is countries such as Australia, New Zealand and the United Kingdom.On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.

The market is segmented on the basis of product type, container design, dosage form, prescription/availability, therapeutic class, application, and end-user. On the basis of product type the global nasal spray market is segmented into decongestion nasal spray, salt water solution/ saline nasal spray, and steroid nasal spray. On the basis of end-user the global nasal spray market is segmented into hospitals, clinics, home care settings, pharmacies, and community health care.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the nasal spray market with 52.1% market share followed by Europe and APAC.

   FIGURE: ASIA PACIFICIS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR NASAL SPRAY MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024

#GLOBAL #NASAL #SPRAY #MARKET

The global nasal spray market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are: In October 2016, Adapt Pharma received Health Canada approval for its naloxone hydrochloride nasal spray which is used for the treatment of opioid overdose. The report includes company share data for different geographies including Global, North America, Europe and APAC.

The global nasal spray market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market Sandoz International,Catalent , Pfizer, AptarGroup, Inc., Nastech pharmaceutical, Adapt Pharma, Inc,Mylan N.V, Innovus  pharmaceuticals, Allergan PLC, Nephron pharmaceutical corporation, Cipla ltd, Meda pharmaceuticals, Inc., Sunovion pharmaceuticals, Teva respiratory, Llc.,  Apotexcorp, Novartis, Valent pharmaceuticals international, Inc., among others.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Choose Licence Type

Enterprise, Single User

Want create site? Find Free WordPress Themes and plugins.

1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL NASAL SPRAY MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                1.2.1. CURRENCY AND PRICING 
                1.2.2. LIMITATION
                1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL NASAL SPRAY MARKET SIZE
                2.2.1. MARKET CRACKDOWN APPROACH 
                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.2.3. DATA TRIANGULATION
                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
                2.2.6. PORTER’S FIVE FORCES MATRIX
       2.3. GLOBAL NASAL SPRAY MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. GLOBAL NASAL SPRAY MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                4.3.1. DRIVERS
                            4.3.1.1. IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY
                            4.3.1.2. EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
                4.3.2. RESTRAINTS
                            4.3.2.1. DRUG FAILURES
                            4.3.2.2. COMPLIANCE OF INHALING NASAL SPRAYS
                4.3.3. OPPURTUNITIES
                            4.3.3.1. RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY
                            4.3.3.2. EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
                4.3.4. THREATS
                            4.3.4.1. PRODUCT RECALLS
                            4.3.4.2. REGULATORY HURDLES
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. NASAL SPRAY MARKET, BY PRODUCT TYPE

       5.1. OVERVIEW
       5.2. DECONGESTION NASAL SPRAY
       5.3. SALT WATER SOLUTION/ SALINE NASAL SPRAY
       5.4. STEROID NASAL SPRAY

6. NASAL SPRAY MARKET, BY CONTAINER DESIGN

       6.1. OVERVIEW
       6.2. PRESSURIZED CANISTERS
       6.3. PUMP BOTTLES

7. NASAL SPRAY MARKET, BY DOSAGE FORM

       7.1. OVERVIEW
       7.2. UNIT/SINGLE DOSE
       7.3. BI DOSE
       7.4. MULTI DOSE

8. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY

       8.1. OVERVIEW
       8.2. PRESCRIBED
       8.3. OVER THE COUNTER

9. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS

       9.1. OVERVIEW
       9.2. ANTIHISTAMINE
       9.3. NASAL STEROIDS
       9.4. MAST CELL INHIBITOR
       9.5. ANTICHOLINERGIC

10. NASAL SPRAY MARKET, BY APPLICATION

       10.1. OVERVIEW
       10.2. ALLERGIC AND NON-ALLERGIC RHINITIS
       10.3. NASAL CONGESTION
       10.4. CENTRAL NERVOUS SYSTEM DISORDERS
       10.5. VACCINATION
       10.6. OTHERS

11. NASAL SPRAY MARKET, BY END USER

       11.1. OVERVIEW
       11.2. HOSPITALS
       11.3. CLINICS
       11.4. HOME CARE SETTINGS
       11.5. PHARMACIES
       11.6. COMMUNITY HEALTH CARE

12. NASAL SPRAY MARKET, BY GEOGRAPHY

12.1.     COUNTRYWISE NASAL SPRAY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                12.1.1.  NORTH AMERICA
                             12.1.1.1.      U.S.
                             12.1.1.2.      CANADA
                             12.1.1.3.      MEXICO
                12.1.2. EUROPE
                             12.1.2.1.      GERMANY
                             12.1.2.2.      FRANCE
                             12.1.2.3.      U.K.
                             12.1.2.4.      ITALY
                             12.1.2.5.      SPAIN
                             12.1.2.6.      RUSSIA
                             12.1.2.7.      TURKEY
                             12.1.2.8.      BELGIUM
                             12.1.2.12.      NETHERLANDS
                             12.1.2.13.      SWITZERLAND
                             12.1.2.14.    REST OF EUROPE
                12.1.3. ASIA-PACIFIC (APAC)
                             12.1.3.1.      JAPAN
                             12.1.3.2.      CHINA
                             12.1.3.3.      SOUTH KOREA
                             12.1.3.4.      INDIA
                             12.1.3.5.      AUSTRALIA
                             12.1.3.6.      SINGAPORE
                             12.1.3.7.      THAILAND
                             12.1.3.8.      MALAYSIA
                             12.1.3.12.      INDONESIA
                             12.1.3.13.      PHILIPPINES
                             12.1.3.14.      REST OF APAC
                12.1.4. LATIN AMERICA
                             12.1.4.1.     BRAZIL
                             12.1.4.2.     REST OF LATIN AMERICA
                12.1.5. MIDDLE EAST AND AFRICA
                             12.1.5.1.     SOUTH AFRICA
                             12.1.5.2.     REST OF MIDDLE EAST AND AFRICA
       12.2.     KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

13. NASAL SPRAY MARKET: COMPETITIVE LANDSCAPE

       13.1.      GLOBAL NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.2.     U.S. NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.3.     EUROPE NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.4.     APAC NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.5.     SOUTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.6.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
       13.7.     MERGERS & ACQUISITIONS
       13.8.     NEW PRODUCT DEVELOPMENT & APPROVALS
       13.9.   EXPANSIONS
       13.10.   REGULATORY CHANGES
       13.11.   PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS            

14. NASAL SPRAY MARKET, COMPANY PROFILES

       14.1.  SANDOZ INTERNATIONAL
                   14.1.1   COMPANY OVERVIEW
                   14.1.2   SWOT ANALYSIS
                   14.1.3   REVENUE ANALYSIS
                   14.1.4   PRODUCT PORTFOLIO
                   14.1.5   RECENT DEVELOPEMENTS
                   14.1.5   DATA BRIDGE ANALYSIS
       14.2. CATALENT
                   14.2.1   COMPANY OVERVIEW
                   14.2.2   SWOT ANALYSIS
                   14.2.3   REVENUE ANALYSIS
                   14.2.4   PRODUCT PORTFOLIO
                   14.2.5   RECENT DEVELOPEMENTS
                   14.2.5   DATA BRIDGE ANALYSIS
       14.3. PFIZER, INC.
                   14.3.1   COMPANY OVERVIEW
                   14.3.2   SWOT ANALYSIS
                   14.3.3   REVENUE ANALYSIS
                   14.3.4   PRODUCT PORTFOLIO
                   14.3.5   RECENT DEVELOPEMENTS
                   14.3.5   DATA BRIDGE ANALYSIS
       14.4. PFEIFFER GMBH
                   14.4.1   COMPANY OVERVIEW
                   14.4.2   SWOT ANALYSIS
                   14.4.3   REVENUE ANALYSIS
                   14.4.4   PRODUCT PORTFOLIO
                   14.4.5   RECENT DEVELOPEMENTS
                   14.4.5   DATA BRIDGE ANALYSIS
       14.5. NASTECH PHARMACEUTICAL
                   14.5.1   COMPANY OVERVIEW
                   14.5.2   SWOT ANALYSIS
                   14.5.3   REVENUE ANALYSIS
                   14.5.4   PRODUCT PORTFOLIO
                   14.5.5   RECENT DEVELOPEMENTS
                   14.5.5   DATA BRIDGE ANALYSIS
       14.6. ADAPT PHARMA, INC.
                   14.6.1   COMPANY OVERVIEW
                   14.6.2   SWOT ANALYSIS
                   14.6.3   REVENUE ANALYSIS
                   14.6.4   PRODUCT PORTFOLIO
                   14.6.5   RECENT DEVELOPEMENTS
                   14.6.5   DATA BRIDGE ANALYSIS
       14.7.  MYLAN N.V.                                                                                                                                                    
                   14.7.1   COMPANY OVERVIEW
                   14.7.2   SWOT ANALYSIS
                   14.7.3   REVENUE ANALYSIS
                   14.7.4   PRODUCT PORTFOLIO
                   14.7.5   RECENT DEVELOPEMENTS
                   14.7.5   DATA BRIDGE ANALYSIS
       14.8. INNOVUS PHARMACEUTICALS
                   14.8.1   COMPANY OVERVIEW
                   14.8.2   SWOT ANALYSIS
                   14.8.3   REVENUE ANALYSIS
                   14.8.4   PRODUCT PORTFOLIO
                   14.8.5   RECENT DEVELOPEMENTS
                   14.8.5   DATA BRIDGE ANALYSIS
       14.9. ALLERGAN PLC
                   14.9.1   COMPANY OVERVIEW
                   14.9.2   SWOT ANALYSIS
                   14.9.3   REVENUE ANALYSIS
                   14.9.4   PRODUCT PORTFOLIO
                   14.9.5   RECENT DEVELOPEMENTS
                   14.9.5   DATA BRIDGE ANALYSIS
       14.10. NEPHRON PHARMACEUTICALS CORPORATION
                     14.10.1   COMPANY OVERVIEW
                     14.10.2   SWOT ANALYSIS
                     14.10.3   REVENUE ANALYSIS
                     14.10.4   PRODUCT PORTFOLIO
                     14.10.5   RECENT DEVELOPEMENTS
                     14.10.5   DATA BRIDGE ANALYSIS
       14.11. CIPLA LTD
                     14.11.1   COMPANY OVERVIEW
                     14.11.2   SWOT ANALYSIS
                     14.11.3   REVENUE ANALYSIS
                     14.11.4   PRODUCT PORTFOLIO
                     14.11.5   RECENT DEVELOPEMENTS
                     14.11.5   DATA BRIDGE ANALYSIS
       14.12. MEDA PHARMACEUTICALS, INC.
                     14.12.1   COMPANY OVERVIEW
                     14.12.2   SWOT ANALYSIS
                     14.12.3   REVENUE ANALYSIS
                     14.12.4   PRODUCT PORTFOLIO
                     14.12.5   RECENT DEVELOPEMENTS
                     14.12.5   DATA BRIDGE ANALYSIS
       14.13. SUNOVION PHARMACEUTICALS INC.
                     14.13.1   COMPANY OVERVIEW
                     14.13.2   SWOT ANALYSIS
                     14.13.3   REVENUE ANALYSIS
                     14.13.4   PRODUCT PORTFOLIO
                     14.13.5   RECENT DEVELOPEMENTS
                     14.13.5   DATA BRIDGE ANALYSIS
       14.14. TEVA RESPIRATORY, LLC.
                     14.14.1   COMPANY OVERVIEW
                     14.14.2   SWOT ANALYSIS
                     14.14.3   REVENUE ANALYSIS
                     14.14.4   PRODUCT PORTFOLIO
                     14.14.5   RECENT DEVELOPEMENTS
                     14.14.5   DATA BRIDGE ANALYSIS
       14.15. APOTEX CORP.
                     14.15.1   COMPANY OVERVIEW
                     14.15.2   SWOT ANALYSIS
                     14.15.3   REVENUE ANALYSIS
                     14.15.4   PRODUCT PORTFOLIO
                     14.15.5   RECENT DEVELOPEMENTS
                     14.15.5   DATA BRIDGE ANALYSIS

15. APPENDIX

       15.1. RELATED REPORTS
       15.2. CUSTOMIZABLE OPTIONS
       15.3. SOURCE SHEET

16. ABOUT DATA BRIDGE MARKET RESEARCH

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Please fill in the below form and our sales representatives will get back to you.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
`
Show Buttons
Hide Buttons